Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study-Reference-Cited by-同舟云学术

Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study

Published:2019-02 Issue:2 Volume:20 Page:216-228
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Bromberg Jacoline E C,Issa Samar,Bakunina Katerina,Minnema Monique C,Seute Tatjana,Durian Marc,Cull Gavin,Schouten Harry C,Stevens Wendy B C,Zijlstra Josee M,Baars Joke W,Nijland Marcel,Mason Kylie D,Beeker Aart,van den Bent Martin J,Beijert Max,Gonzales Michael,de Jong Daphne,Doorduijn Jeanette K

Funder

Dutch Cancer Society

Publisher

Elsevier BV

Subject

Oncology

Reference33 articles.

1. Improved survival in primary central nervous system lymphoma up to age 70 only: a population-based study on incidence, primary treatment and survival in the Netherlands, 1989–2015;van der Meulen;Leukemia,2017

2. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma;Villano;Br J Cancer,2011

3. Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology;Hoang-Xuan;Lancet Oncol,2015

4. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group phase 2 trial 20962;Poortmans;J Clin Oncol,2003

5. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial;Thiel;Lancet Oncol,2010

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Postoperative Chemotherapy on Survival in Patients with Primary Central Nervous System Lymphoma: A Study Based on the SEER Database;British Journal of Hospital Medicine;2024-09-13

2. Sintilimab (anti-PD-1 antibody) combined with high-dose methotrexate, temozolomide, and rituximab (anti-CD20 antibody) in primary central nervous system lymphoma: a phase 2 study;Signal Transduction and Targeted Therapy;2024-09-04

3. Isolated primary CNS lymphoma after liver transplantation for autoimmune hepatitis: a case report;BMC Neurology;2024-08-30

4. Prognostic Impacts of Age, Diagnosis Time, and Relapses in Primary CNS Lymphoma;Journal of Clinical Medicine;2024-08-13

5. Combination of rituximab and methotrexate followed by rituximab and cytarabine in elderly patients with primary central nervous system lymphoma;British Journal of Haematology;2024-08-05